Inflammatory pathways and cardiac repair: the affliction of infarction

Recent advances have improved our ability to treat the acute symptoms of myocardial infarction, but have done little to prevent the chronic complications that arise afterward. New data suggest that targeting the plasminogen activator and matrix metalloproteinase pathways inhibit adaptive and maladaptive changes that follow myocardial infarction. (pages 1135–1142)

[1]  P. Libby,et al.  Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. , 1999, Circulation.

[2]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[3]  J. Ross,et al.  Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress , 1999, Cell.

[4]  D. Hanahan,et al.  Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. , 1999, Genes & development.

[5]  K. Chien,et al.  Stress Pathways and Heart Failure , 1999, Cell.

[6]  P. Carmeliet,et al.  Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system. , 1998, Thrombosis research.

[7]  K. Chien,et al.  Signaling pathways for cardiac hypertrophy and failure. , 1999, The New England journal of medicine.

[8]  A. Luttun,et al.  Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure , 1999, Nature Medicine.

[9]  J. Ross,et al.  Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Daemen,et al.  Chronic myocardial infarction in the mouse: cardiac structural and functional changes. , 1999, Cardiovascular research.

[11]  P. Doevendans,et al.  Cardiovascular phenotyping in mice. , 1998, Cardiovascular research.

[12]  M. Zile,et al.  Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function. , 1999, Circulation research.